Anthera Pharmaceuticals Stock Price To Sales
ANTHDelisted Stock | USD 0.0001 0.00 0.00% |
Anthera Pharmaceuticals fundamentals help investors to digest information that contributes to Anthera Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Anthera Pink Sheet. The fundamental analysis module provides a way to measure Anthera Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Anthera Pharmaceuticals pink sheet.
Anthera |
Anthera Pharmaceuticals Company Price To Sales Analysis
Anthera Pharmaceuticals' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Anthera Pharmaceuticals has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to sales for all United States stocks is 100.0% higher than that of the company.
Anthera Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Anthera Pharmaceuticals' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Anthera Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Anthera Pharmaceuticals by comparing valuation metrics of similar companies.Anthera Pharmaceuticals is currently under evaluation in price to sales category among its peers.
Anthera Fundamentals
Return On Equity | -5.69 | ||||
Return On Asset | -1.42 | ||||
Current Valuation | (7.47 M) | ||||
Shares Outstanding | 26.18 M | ||||
Number Of Shares Shorted | 2.02 M | ||||
Price To Earning | (0.20) X | ||||
Price To Book | 0.11 X | ||||
Gross Profit | (28.49 M) | ||||
EBITDA | (26.59 M) | ||||
Net Income | (26.87 M) | ||||
Cash And Equivalents | 8.09 M | ||||
Cash Per Share | 0.31 X | ||||
Debt To Equity | 1.61 % | ||||
Current Ratio | 3.30 X | ||||
Book Value Per Share | 0.21 X | ||||
Cash Flow From Operations | (36.9 M) | ||||
Short Ratio | 2.09 X | ||||
Earnings Per Share | (1.76) X | ||||
Price To Earnings To Growth | (0.05) X | ||||
Target Price | 3.0 | ||||
Number Of Employees | 21 | ||||
Beta | -108.04 | ||||
Market Capitalization | 617.83 K | ||||
Total Asset | 3.67 M | ||||
Retained Earnings | (436.8 M) | ||||
Working Capital | 39.39 M | ||||
Current Asset | 47.86 M | ||||
Current Liabilities | 8.47 M | ||||
Net Asset | 3.67 M |
About Anthera Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Anthera Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anthera Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anthera Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Anthera Pink Sheet
If you are still planning to invest in Anthera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anthera Pharmaceuticals' history and understand the potential risks before investing.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Stocks Directory Find actively traded stocks across global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |